The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Autophagy inhibition (AI) as a novel treatment strategy in bladder cancer (BC).
 
Petros Grivas
Honoraria - Myriad Genetics
Consulting or Advisory Role - Dendreon; Genentech; Myriad Genetics
Research Funding - Bayer (Inst); Genentech/Roche (Inst); Genmab (Inst); Merck (Inst); Mirati Therapeutics (Inst); Oncogenex (Inst)
 
Valeria Visconte
Patents, Royalties, Other Intellectual Property - Cleveland Clinic
 
Mark L. Day
Honoraria - Pharco Pharmaceuticals
Consulting or Advisory Role - Pharco Pharmaceuticals
Research Funding - European Egyptian Pharmaceutical Industries; Genmab; Synthon
 
Kathleen C. Day
Honoraria - Pharco Pharmaceuticals (I)
Consulting or Advisory Role - Pharco Pharmaceuticals (I)
Research Funding - European Egyptian Pharmaceutical Industries (I); Genmab (I); Synthon (I)
 
Monica Liebert
No Relationships to Disclose
 
Phillip Lee Palmbos
No Relationships to Disclose
 
Scott A. Tomlins
Honoraria - Ventana Medical Systems
Consulting or Advisory Role - Ventana Medical Systems
Research Funding - Thermo Fisher Scientific (Inst)
Patents, Royalties, Other Intellectual Property - I am a coauthor on a patent issued to the University of Michigan on ETS gene fusions in prostate cancer. The diagnostic field of use has been licensed to Hologic/Gen-Probe Inc., who has sublicensed some rights to Ventana Medical Systems/Roche.
 
Jennifer Carew
Patents, Royalties, Other Intellectual Property - Cleveland Clinic; Spectrum Pharmaceuticals